Archives

by in
Entry Author Date Location
Boston Biotech Seizes the Momentum: Last Chance for Early Bird Tix 03/07/13 Boston
If You’ve Got a Real Breakthrough, the FDA Wants To Talk 01/14/13 National
Vertex Gets FDA Go-Ahead To Sell New Cystic Fibrosis Drug 01/31/12 Boston
Vertex Vows to Fight On With Alios Drugs in High-Stakes Hepatitis C Race 01/24/12 Boston
Vertex, Ariad, Alnylam, & More Boston-Area Life Sciences Newsmakers 12/16/11 Boston
Vertex Names Jeff Leiden as New CEO, Staring Down Tough Competition 12/15/11 Boston
Lycera CEO Resigns After Less Than One Year, Michigan Startup Plans to Keep Boston Presence 09/17/10 Detroit
Lycera Keeps Its Investors Happy, Snags $11M to Pursue New Autoimmune Drugs 04/28/10 Detroit
Catabasis Pharmaceuticals Pockets $7.7M out of $40M Venture Round 04/15/10 Boston
Lycera, a Midwestern Biotech Star, Moves Head Office to Boston, Hires Biogen Vet as CEO 01/07/10 Boston
Biotech Pioneer Steve Gillis on Life as a VC, How Today’s Entrepreneurs Can Make It, and Seattle’s Future in Life Sciences (Part 1) 09/23/09 Seattle
Page 1 of 1